Skip to main content
Caplight Logo









immunitoAI

immunitoAI

Private
BangaloreHealthcare & Life Scienceshttps://www.immunitoai.com/

Last Round

Series A

Nov 26, 2025

Total Funding Raised

$7.16M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

immunitoAI is a biotechnology company that has developed an AI-powered platform for antibody discovery intended to accelerate the development of novel antibody therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

generative AIantibody discoveryde novo antibody designAI drug discoveryantibody therapeuticsTechBiogenerative biologycomputational drug designin silico drug discoverywet lab validationbiologics discoverycustom antibody developmentantibody engineeringaffinity maturation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

immunitoAI Comparables

Compare immunitoAI with similar companies based on industry and business-model similarity.

immunitoAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Antiverse
88%
DenovAI Biotech
86%
Aureka
85%

immunitoAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 26, 2025
SeedSep 8, 2021
Pre SeedNov 1, 2020

Key People

Founding team and executive leadership

Trisha Chatterjee

Co-Founder and CTO

Founding Team

Aridni Shah

Co-founder and CEO

Founding Team

immunitoAI Investors

Notable investors and investment history

immunitoAI investors
InvestorRounds
LetsVenture OnlineSeries A
pi VenturesSeries A, Seed
3one4 CapitalSeries A
Entrepreneurs FirstSeed, Pre Seed
AC VenturesSeries A
Anicut CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 111% MoM.

  • Feb 3, 2026

    Monthly visitors increased 169% MoM, reaching 11.9K.

immunitoAI Filings

Explore SEC and related filing metadata, where available.

immunitoAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about immunitoAI's valuation, stock price, and market status.

Is immunitoAI a public or private company?

immunitoAI is a private company.

What is the current stock price of immunitoAI?

immunitoAI is a private company with no public stock price. No recent secondary market data is available.

How much is immunitoAI worth (valuation)?

Valuation information for immunitoAI is not publicly available.

Can I buy immunitoAI stock?

immunitoAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was immunitoAI's last funding round?

Funding round information for immunitoAI is not publicly available.

Who are the main investors in immunitoAI?

Investor information for immunitoAI is not publicly disclosed.

Will immunitoAI IPO soon?

No public IPO plans have been announced for immunitoAI.

How can I track immunitoAI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor immunitoAI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range19
Year Founded2020
Last FundingNov 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?